Fig. 1From: The clinical utility and costs of whole-genome sequencing to detect cancer susceptibility variants—a multi-site prospective cohort studyScenarios used as the basis of the health economic analysis. Scenario 1: Standard testing; Scenario 2: standard testing followed by whole-genome sequencing (WGS); Scenario 3 upfront WGS. FCC—familial cancer centre; MDT—multi-disciplinary team meetingBack to article page